Skip to content

Drug interactions

Certolizumab pegol + Rilonacept

Severity: Major

Certolizumab pegol and Rilonacept: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs block cytokines (TNF and IL-1) central to host defence. Using them together raises the risk of serious infections. Labeling for IL-1 blockers advises against combining with TNF inhibitors.

What this interaction means in plain words

Certolizumab pegol and Rilonacept can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Certolizumab pegol belongs to Musculoskeletal; Rilonacept belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Additive immunosuppression through TNF and IL-1 blockade.

What to do

Avoid concurrent use and choose one agent. If combined, monitor closely for signs of infection and stop at the first serious infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Certolizumab pegol and Rilonacept, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Certolizumab pegol with Rilonacept?

MediHelp rates the interaction as major. Certolizumab pegol and Rilonacept can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs block cytokines (TNF and IL-1) central to host defence. Using them together raises the risk of serious infections. Labeling for IL-1 blockers advises against combining with TNF inhibitors.

How serious is the interaction between Certolizumab pegol and Rilonacept?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use and choose one agent. If combined, monitor closely for signs of infection and stop at the first serious infection.

What other medicines interact with Certolizumab pegol?

MediHelp also lists interactions of Certolizumab pegol with, for example, Adenovirus types 4 and 7 live, Bcg intravesical live, Bcg vaccine live. The full list is on the Certolizumab pegol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in